Both inducible nitric oxide synthase and NADPH oxidase contribute to the control of virulent phase I Coxiella burnetii infections

Infection and Immunity

Volumn 72, Issue 11, 2004, Pages 6666-6675

  Brennan, Robert E ^a   Russell, Kasi ^a   Zhang, Guoquan ^a   Samuel, James E ^a  

^a TEXAS A AND M HEALTH SCIENCE CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CATALASE; CYTOKINE; GAMMA INTERFERON; HYDROGEN PEROXIDE; INDUCIBLE NITRIC OXIDE SYNTHASE; N(G) METHYLARGININE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE INHIBITOR; REACTIVE NITROGEN SPECIES; REACTIVE OXYGEN METABOLITE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BACTERIAL GROWTH; BACTERIAL INFECTION; BACTERIAL VIRULENCE; CONTROLLED STUDY; COXIELLA BURNETII; HOST; INFECTION CONTROL; KNOCKOUT MOUSE; MACROPHAGE ACTIVATION; MONOCYTE; MOUSE; NONHUMAN; PRIORITY JOURNAL; WILD TYPE;

ANIMALS; CELL LINE; CELLS, CULTURED; COXIELLA BURNETII; HYDROGEN PEROXIDE; MACROPHAGE ACTIVATION; MACROPHAGES, PERITONEAL; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; NADPH OXIDASE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE TYPE II; Q FEVER; VIRULENCE;

EID: 7044254894     PISSN: 00199567     EISSN: None     Source Type: Journal    
DOI: 10.1128/IAI.72.11.6666-6675.2004     Document Type: Article

References (57)

1. Adams, D. O., and T. A. Hamilton. 1984. The cell biology of macrophage activation. Annu. Rev. Immunol. 2:283-318.
2. Adams, L. B., M. C. Dinauer, D. E. Morgenstern, and J. L. Krahenbuhl. 1997. Comparison of the roles of oxygen and nitrogen intermediates in the host response to mycobacterium tuberculosis using transgenic mice. Tuber. Lung Dis. 78:237-246.
3. Akporiaye, E. T., and O. G. Baca. 1983. Superoxide anion production and superoxide dismutase and catalase activities in Coxiella burnetii. J. Bacteriol. 154:520-523.
4. Akporiaye, E. T., J. D. Rowatt, A. A. Aragon, and O. G. Baca. 1983. Lysosomal response of a murine macrophage-like cell line persistently infected with Coxiella burnetii. Infect. Immun. 40:1155-1162.
5. Akporiaye, E. T., D. Stefanovich, V. Tsosie, and G. Baca. 1990. Coxiella burnetii fails to stimulate human neutrophil superoxide anion production. Acta Virologica 34:64-70.
6. Andoh, M., T. Naganawa, A. Hotta, T. Yamaguchi, H. Fukushi, T. Masegi, and K. Hirai. 2003. SCID mouse model for lethal Q fever. Infect. Immun. 71:4717-4723.
7. Asher, M. S., P. B. Jahrling, D. G. Harrington, R. A. Kishimoto, and V. G. McGann. 1980. Mechanisms of protective immunogenicity of microbial vaccines: effects of cyclophosphamide pretreatment in Venezuelan encephalitis, Q fever, and tularemia. Clin. Exp. Immunol. 41:225-236.
8. d) mice infected with the Nine Mile isolate of C burnetii. J. Infect. Dis. 170:223-226.
9. Babudieri, C. 1959. Q fever: a zoonosis. Adv. Vet. Sci. 5:81-84.
10. Bandyopadhyay, P., B. Byrne, Y. Chan, M. S. Swanson, and H. M. Steinman. 2003. Legionella pneumophila catalase-peroxidases are required for proper trafficking and growth in primary macrophages. Infect. Immun. 71:4526-4535.
11. Bandyopadhyay, P., and H. M. Steinman. 2000. Catalase-peroxidases of Legionella pneumophila: cloning of the katA gene and studies of KatA function. J. Bacteriol. 182:6679-6686.
12. Beauchamp, C., and I. Fridovich. 1970. A mechanism for the production of ethylene from methional. The generation of the hydroxyl radical by xanthine oxidase. J. Biol. Chem. 245:4641-4646.
13. Beron, W., M. G. Gutierrez, M. Rabinovitch, and M. I. Colombo. 2002. Coxiella burnetii localizes in a Rab7-labeled compartment with autophagic characteristics. Infect. Immun. 70:5816-5821.
14. Brennan, R. E., and J. E. Samuel. 2003. Evaluation of Coxiella burnetii antibiotic susceptibilities by real-time PCR assay. J. Clin. Microbiol. 41:1869-1874.
15. Capo, C., Y. Zaffran, F. Zugan, P. Houpikian, D. Raoult, and J. L. Mege. 1996. Production of interleukin-10 and transforming growth factor β by peripheral blood mononuclear cells in Q fever endocarditis. Infect. Immun. 64:4143-1150.
16. Cohn, Z. A. 1978. The activation of mononuclear phagocytes: fact, fancy, future. J. Immunol. 121:813-816.
17. Clark, R. A. 1990. The human neutrophil respiratory burst oxidase. J. Infect. Dis. 161:1140-1147.
18. Damiani, G., C. Kiyotaki, W. Soeller, M. Sasada, J. Peisach, and B. R. Bloom. 1980. Macrophage variants in oxygen metabolism. J. Exp. Med. 152:808-822.
19. Darrah, P. A., M. K. Hondalus, Q. Chen, H. Ischiropoulos, and D. M. Mosser. 2000. Cooperation between reactive oxygen and nitrogen intermediates in killing of Rhodococcus equi by activated macrophages. Infect. Immun. 68:3587-3593.
20. Dellacasagrande, J., C. Capo, D. Raoult, and J.-L. Mege. 1999. IFN-γ-mediated control of Coxiella burnetii survival in monocytes: the role of cell apoptosis and TNF. J. Immunol. 176:2259-2265.
21. Fang, F. C. 1997. Mechanisms of nitric oxide related antimicrobial activity. J. Clin. Investig. 99:2818-2825.
22. Feng, H. M., and D. H. Walker. 2000. Mechanisms of intracellular killing of Rickettsia conorii in infected human endothelial cells, hepatocytes, and macrophages. Infect. Immun. 68:6729-6736.
23. Gebran, S. J., Y. Yamamoto, C. Newton, T. W. Klein, and H. Friedman. 1994. Inhibition of Legionella pneumophila growth by gamma interferon in permissive A/J mouse macrophages: role of reactive oxygen species, nitric oxide, tryptophan, and iron (III). Infect. Immun. 62:3197-3205.
24. Goldberg, M., L. S. Belkowski, and B. R. Bloom. 1990. Regulation of macrophage function by interferon-gamma. Somatic cell genetic approaches in murine macrophage cell lines to mechanisms of growth inhibition, the oxidative burst, and expression of the chronic granulomatous disease gene. J. Clin. Investig. 85:563-569.
25. G-monomethyl-L-arginine. J. Immunol. 146:1294-1302.
26. Gupta, S. L., J. M. Carlin, P. Pyati, W. Dai, E. R. Pfefferkorn, and M. J. Murphy, Jr. 1994. Antiparasitic and antiproliferative effects of indoleamine 2,3-dioxygenase enzyme expression in human fibroblasts. Infect. Immun. 62:2277-2284.
27. Haas, A., and W. Goebel. 1992. Microbial strategies to prevent oxygen-dependent killing by phagocytes. Free Radic. Res. Commun. 16:137-157.
28. Haber, F., and J. Weiss. 1934. The catalytic decomposition of hydrogen peroxide by iron salts. Proc. R. Soc. Lond. A 147:332-351.
29. Hackstadt, T., M. G. Peacock, P. J. Hitchcock, and R. L. Cole. 1985. Lipopolysaccharide variation in Coxiella burnetii: interstrain heterogeneity in structure and antigenicity. Infect. Immun. 48:359-365.
30. Hibbs, J. B., Jr., Z. Vavrin, and R. R. Taintor. 1987. L-Arginine is required for expression of the activated macrophage effector mechanism causing selective metabolic inhibition in target cells. J. Immunol. 138:550-565.
31. Hinrichs, D. J., and T. R. Jerrells. 1976. In vitro evaluation of immunity to Coxiella burnetii. J. Immunol. 117:996-1003.
32. Howe, D., L. F. Barrows, N. M. Lindstrom, and R. A. Heinzen. 2002. Nitric oxide inhibits Coxiella burnetii replication and parasitophorous vacuole maturation. Infect. Immun. 70:5140-5147.
33. Izzo, A. A., and B. A. Marmion. 1993. Variation in interferon-γ responses to Coxiella burnetii antigens with lymphocytes from vaccinated and naturally infected subjects. Clin. Exp. Immunol. 94:507-514.
34. Jackett, P. S., V. R. Aber, and D. B. Lowrie. 1978. Virulence and resistance to superoxide, low pH, and hydrogen peroxide among strains of Mycobacterium tuberculosis. J. Gen. Microbiol. 104:37-45.
35. Jiang, X., B. Leonard, R. Bensen, and C. L. Baldwin. 1993. Macrophage control of Brucella abortus: role of reactive oxygen intermediates and nitric oxide. Cell. Immunol. 151:309-319.
36. Kishimoto, R. A., H. Rozmiarek, and R. W. Larson. 1978. Experimental Q fever infection in congenitally athymic nude mice. Infect. Immun. 22:69-71.
37. Korshunov, S. S., and J. A. Imlay. 2002. A potential role for periplasmic superoxide dismutase in blocking the penetration of external superoxide into the cytosol of gram-negative bacteria. Mol. Microbiol. 43:95-106.
38. MacMicking, J. D., R. J. North, R. LaCourse, J. S. Mudgett, S. K. Shah, and C. F. Nathan. 1997. Identification of nitric oxide synthase as a protective locus against tuberculosis. Proc. Natl. Acad. Sci. USA 94:5243-5248.
39. Manor, E., and I. Sarov. 1990. Inhibition of Rickettsia conorii growth by recombinant tumor necrosis factor alpha: enhancement of inhibition by gamma interferon. Infect. Immun. 58:1886-1890.
40. Marrie, T. J. 1990. Epidemiology of Q fever, p. 49-70. In T. J. Marrie (ed.), Q fever, vol. 1. The disease. CRC Press, Boca Raton, Fla.
41. Miller, R. A., and B. E. Britigan. 1995. The formation and biological significance of phagocyte-derived oxidants. J. Investig. Med. 43:39-49.
42. Miller, R. A., and B. E. Britigan. 1997. Role of oxidants in microbial pathophysiology. Clin. Microbiol. Rev. 10:1-18.
43. Murray, H. W., and D. M. Cartelli. 1983. Killing of intracellular Leishmania donovani by human mononuclear phagocytes: evidence for oxygen-dependent and -independent leishmanicidal activity. J. Clin. Investig. 72:32-39.
44. Murray, H. W., and C. F. Nathan. 1999. Macrophage microbicidal mechanisms in vivo: reactive nitrogen versus oxygen intermediates in the killing of intracellular visceral Leishmania donovani. J. Exp. Med. 189:741-746.
45. Pacelli, R., D. A. Wink, J. A. Cook, M. C. Krishna, W. DeGraff, N. Friedman, M. Tsokos, A. Samuni, and J. B. Mitchell. 1995. Nitric oxide potentiates hydrogen peroxide-induced killing of Escherichia coli. J. Exp. Med. 182:1469-1479.
46. Pfefferkorn, E. R. 1984. Interferon-gamma blocks the growth of Toxoplasma gondii in human fibroblasts by inducing the host cell to degrade tryptophan. Proc. Natl. Acad. Sci. USA 81:908-912.
47. Pick, E. 1986. Microassays for superoxide and hydrogen peroxide production and nitroblue tetrazolium reduction using an enzyme immunoassay microplate reader. Methods Enzymol. 132:407-421.
48. Raoult, D. 1990. Host factors in the severity of Q fever. Ann. N. Y. Acad. Sci. 590:33-38.
49. Raoult, D. 1993. Treatment of Q fever. Antimicrob. Agents Chemother. 37:1733-1736.
50. Raoult, D., P. Brouqui, B. Marchou, and J.-A. Gastaut. 1992. Acute and chronic Q fever patients with cancer. Clin. Infect. Dis. 14:127-130.
51. Raoult, D., P. Houpikian, H. Tissot Dupont, M. J. Riss, J. Arditi-Djiane, and P. Brouqui. 1999. Comparison of 2 regimens containing doxycycline and ofloxacin or hydroxychloroquine. Arch. Intern. Med. 159:167-273.
52. Scanga, C. A., V. P. Mohan, K. Tanaka, D. Alland, J. L. Flynn, and J. Chan. 2001. The inducible nitric oxide synthase locus confers protection against aerogenic challenge of both clinical and laboratory strains of Mycobacterium tuberculosis in mice. Infect. Immun. 69:7711-7717.
53. St. John, G., and H. M. Steinman. 1996. Periplasmic copper-zinc superoxide dismutase of Legionella pneumophila: role in stationary-phase survival. J. Bacteriol. 178:1578-1584.
54. Turco, J., H. A. Thompson, and H. Winkler. 1984. Interferon-γ inhibits growth of Coxiella burnetii in mouse fibroblasts. Infect. Immun. 45:781-783.
55. Vazquez-Torres, A., J. Jones-Carson, P. Mastroeni, H. Ischiropoulos, and F. C. Fang. 2000. Antimicrobial actions of the NADPH phagocyte oxidase and inducible nitric oxide synthase in experimental salmonellosis. I. Effects on microbial killing by activated peritoneal macrophages in vitro. J. Exp. Med. 192:227-236.
56. Weiss, S. J. 1986. Oxygen, ischemia and inflammation. Acta Physiol. Scand. 548(Suppl.):9-37.
57. Zamboni, D. S., and M. Rabinovitch. 2003. Nitric oxide partially controls Coxiella burnetii phase II infection in mouse primary macrophages. Infect. Immun. 71:1225-1233.